Cyclooxygenase-2 Expression in Bladder Cancer and Patient Prognosis: Results from a Large Clinical Cohort and Meta-Analysis

• Maciej J. Czachorowski,

  Affiliation Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain

  ⨯
• André F. S. Amaral,

  Affiliation Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain

  ⨯
• Santiago Montes-Moreno,

  Affiliation Servicio de Anatomía Patológica, Hospital Universitario Marqués de Valdecilla, Santander, Spain

  ⨯
• Josep Lloreta,

  Affiliations Institut Municipal d’Investigació Mèdica – Hospital del Mar, Barcelona, Spain, Departament de Patologia, Hospital del Mar – Parc de Salut Mar, Barcelona, Spain, Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain

  ⨯
• Alfredo Carrato,

  Affiliations Hospital General Universitario de Elche, Elche, Spain, Hospital Ramon y Cajal, Madrid, Spain

  ⨯
• Adonina Tardón,

  Affiliation Universidad de Oviedo, Oviedo, Spain

  ⨯
• Manuel M. Morente,

  Affiliation Tumor Bank Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain

  ⨯
• Manolis Kogevinas,

  Affiliation Centre de Recerca en Epidemiologia Ambiental (CREAL), Barcelona, Spain

  ⨯
• Francisco X. Real,

  Affiliations Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain, Epithelial Carcinogenesis Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain

  ⨯
• Núria Malats ,

  * E-mail: nmalats@cnio.es

  Affiliation Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain

  ⨯
• for the SBC/EPICURO investigators

  ¶Membership of the Spanish Bladder Cancer (SBC)/EPICURO Study investigators is provided in the Acknowledgments.

  ⨯